Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950138-15-000246
Filing Date
2015-03-12
Accepted
2015-03-12 13:04:42
Documents
1
Period of Report
2015-03-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5794
  Complete submission text file 0000950138-15-000246.txt   7227
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4800 MAIN STREET SUITE 100 KANSAS CITY MO 64112
Business Address
Sosland Morton I. (Reporting) CIK: 0001585668 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 15695266